ReviewTherapeutics and clinical risk management2016
Secukinumab for ankylosing spondylitis and psoriatic arthritis.
Ennio Lubrano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled ittrialcites it